-
$4,995 Read More Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 – Strong Pipeline and Expanding Treatment Population to [...]
Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity. This has been attributed to a range of factors, including economic develop... -
$4,995 Read More Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 – Advent of Novel Biologics and Expanding Treatment Pool to Drive[...]
GBI Research, the leading business intelligence provider, has released its latest research, "Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth", which provides insights into psoriasis therapeutics in the Asia-P... -
$4,700 Read More Biodefense Market Analysis By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Ebola, Hemorrhagic Fever) And Segment Forecasts [...]
Global biodefense market is expected to reach USD 13.33 billion by 2020. Growing R&D investments in the field of biotechnology coupled with increasing threat of bioterrorism and disease outbreaks is expected to drive market growth during the forecast period. Furthermore, presence of favorable... -
$4,700 Read More Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT[...]
Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by tri... -
$4,700 Read More Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis By Product (Corticosteroids, Intravenous Immunoglobulin, Anti-D [...]
Global ITP therapeutics market is expected to reach USD 566.37 million by 2020. Introduction of new drugs especially pertaining to TPO-RA and IVIG classes is expected to serve this market as a high impact rendering driver. Presence of favorable government regulations such as the Orphan Drug Act i... -
$4,700 Read More Autoimmune Disease Diagnostics Market Analysis By Product (Systemic, Localized, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ank[...]
Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing prevalence of autoimmune diseases coupled with the presence of favorable government initiatives such as the Affordable Care Act is expected to positively reinforce the autoimmune disease diagnosti...
Sorry, there is no ad related to this category!
-
$1,500 Read More Ceronco Biosciences – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Ceronco Biosciences – Product Pipeline Review – 2015’, provides an overview of […]
-
$2,000 Read More Hepatic Encephalopathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hepatic Encephalopathy – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,000 Read More Systemic Sclerosis (Scleroderma) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) – Pipeline Review, H1 2016’, provides an overview of […]
-
$4,995 Read More Breast Cancer Therapeutics in Major Developed Markets to 2021 – Growth Dri...
Breast cancer, a malignant neoplasm, is the second most common cancer and the most common […]
-
$1,500 Read More Hetero Drugs Limited – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Hetero Drugs Limited – Product Pipeline Review – 2015’, provides an overview […]
-
$2,000 Read More Cholera – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cholera – Pipeline Review, H1 2016’, provides an overview of the Cholera […]
-
$2,500 Read More Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Genital Warts (Condylomata […]
-
$4,995 Read More Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 ̵...
Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most […]
-
$2,000 Read More Restless Legs Syndrome – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Restless Legs Syndrome – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Spinal Muscular Atrophy (SMA) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) – Pipeline Review, H1 2016’, provides an overview […]
